YOLFTbeta
00

Shandong Sino-Agri United Biotechnology Co Ltd

003042 · SHE · Basic Materials / Agricultural Inputs

12.26CNY-0.25 (-2.00%)

Price History

Full chart

Market Stats

Previous Close12.51
Open12.55
Day Range12.23 – 12.59
52-Week Range11.04 – 27.95
Volume1.51M
Market Cap2.05B
P/E (TTM)0.00
Forward P/E0.00
EPS-1.28
Dividend Yield0.00%
Beta0.56
50-Day Avg13.73
200-Day Avg15.72

About

Shandong Sino-Agri United Biotechnology Co.,Ltd engages in the development and production of pesticide intermediates and preparation products in China. It offers imidacloprid, acetamiprid, (E)-nitenpyram, pyridaben, intermediates, pesticides, fungicides, and herbicides. The company also exports its products to Southeast Asia, South Asia, the Middle East, Europe, and the United States. Shandong Sino-Agri United Biotechnology Co.,Ltd was founded in 2006 and is based in Jinan, China.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEOMr. Ning Li
  • Employees1.80K
  • HeadquartersNo. 9999, Jingshi Road, Jinan, China, 250014, China
  • Websitehttps://www.sdznlh.com

Leadership

  • Mr. Ning LiGM & Director · b. 1974
  • Mr. Qiang LiFinancial Director · b. 1982
  • Mr. Jianfeng TangChief Engineer · b. 1971
  • Mr. Shijin YanDeputy GM & Board Secretary · b. 1984
  • Mr. Hongsheng JiangDeputy General Manager · b. 1976
  • Ms. Wenli WangDeputy General Manager · b. 1981
  • Yeli ChenAccounting Supervisor

Financials

Income Statement

Currency: CNY2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue907.30M952.31M1.12B1.41B1.37B1.57B1.63B1.93B1.68B2.01B1.86B
Growth (%)-+4.96%+17.79%+25.95%-3.26%+14.74%+3.63%+18.97%-13.06%+19.79%-7.58%
Cost of Revenue656.60M681.08M754.52M862.51M880.46M1.19B1.26B1.57B1.60B1.85B1.67B
Gross Profit250.70M271.23M367.23M550.29M486.33M381.52M361.29M361.73M81.95M159.99M194.72M
Gross Margin27.63%28.48%32.74%38.95%35.58%24.33%22.23%18.71%4.88%7.95%10.46%
Operating Expense151.59M175.89M240.58M267.26M323.78M262.11M252.35M290.04M319.19M295.60M305.19M
Operating Income99.10M95.34M126.66M283.02M162.55M119.40M108.93M71.69M-237.24M-135.61M-110.47M
Operating Margin10.92%10.01%11.29%20.03%11.89%7.61%6.70%3.71%-14.11%-6.73%-5.94%
EBITDA145.51M153.31M227.63M390.78M283.52M249.87M249.07M251.93M-35.10M84.22M93.56M
EBITDA Margin16.04%16.10%20.29%27.66%20.74%15.93%15.33%13.03%-2.09%4.18%5.03%
Net Income84.26M72.90M106.47M243.67M147.14M103.53M98.59M73.14M-192.47M-122.45M-136.61M
Net Income Margin9.29%7.65%9.49%17.25%10.77%6.60%6.07%3.78%-11.45%-6.08%-7.34%
R&D--51.59M70.57M61.35M64.81M73.63M103.91M98.48M86.61M78.82M
R&D as % of Total Revenue--4.60%5.00%4.49%4.13%4.53%5.37%5.86%4.30%4.24%
Interest Expense--32.33M27.80M20.71M25.83M26.13M28.77M36.62M45.03M36.33M
Interest Expense % of Total Revenue--2.88%1.97%1.52%1.65%1.61%1.49%2.18%2.24%1.95%

Balance Sheet

Currency: CNY2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.14B1.41B1.61B1.79B1.89B2.30B3.22B3.54B3.74B3.93B3.82B
Total Liabilities786.42M922.05M1.19B989.66M972.46M1.30B1.59B1.86B2.27B2.58B2.60B
Total Equity355.42M484.85M428.42M800.07M914.09M996.18M1.63B1.68B1.47B1.35B1.22B
Cash85.86M147.12M348.94M263.88M151.21M283.47M575.93M315.81M571.58M425.23M169.01M
Total Debt275.00M493.89M574.38M349.50M346.13M506.05M520.56M570.95M800.39M928.44M-
Net Debt189.14M346.76M225.44M85.62M194.92M222.58M-55.37M255.13M228.81M503.21M625.11M

Cash Flow

Currency: CNY2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow41.84M80.41M244.28M242.67M96.22M114.72M54.41M-40.39M86.90M104.90M13.86M
Investing Cash Flow-38.00M-59.55M-161.86M-92.45M-102.86M-141.04M-334.89M-219.65M-274.01M-322.39M-
Financing Cash Flow812.44K65.72M-49.73M-116.21M-55.96M106.61M492.25M-1.48M417.26M70.61M-
Capital Expenditure38.00M59.73M43.06M12.14M92.50M90.87M244.90M129.15M134.93M174.70M129.50M
Free Cash Flow3.84M20.68M201.22M230.53M3.72M23.85M-190.49M-169.54M-48.03M-69.81M-115.64M
Dividends Paid25.95M105.14M67.71M70.91M32.88M24.66M20.10M21.92M35.24M25.13M20.16M
FCF to OCF9.17%25.71%82.37%95.00%3.86%20.79%-350.11%419.74%-55.27%-66.55%-834.42%
Dividend Paid to FCF676.24%508.50%33.65%30.76%884.48%103.39%-10.55%-12.93%-73.37%-36.00%-17.43%

Earnings

Report DateJun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------
EPS Actual0.030.170.370.170.120.100.130.12-0.20-0.52-0.75-0.15-0.08-0.16-0.470.03-0.01-0.34-0.640.01-0.31
Surprise---------------------
Timing---------------------

Key Statistics & Ratios

Market Cap2.05B
Enterprise Value3.00B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.06
Price / Book1.73
EPS-1.28
Book Value8.28
Revenue (TTM)1.94B
Gross Profit (TTM)109.79M
EBITDA68.79M
Profit Margin-9.38%
Operating Margin-9.67%
Return on Equity-14.34%
Return on Assets-2.59%
Shares Outstanding142.48M
Shares Float65.67M
Beta0.56
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.10Jun 21, 2023
20221×
0.20Jun 22, 2022

Stock Splits

  • Jun 22, 20221.3:1